CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 133670-133889
Annnotations
CORD-19-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T87481 | 0-219 | Sentence | denotes | Our data indicate that in two different therapeutic regimens of active EAN and passive transfer EAN, ABR-215031 administered daily orally effectively ameliorated and inhibited the clinical and pathological signs of EAN. |
Epistemic_Statements
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T285 | 0-219 | Epistemic_statement | denotes | Our data indicate that in two different therapeutic regimens of active EAN and passive transfer EAN, ABR-215031 administered daily orally effectively ameliorated and inhibited the clinical and pathological signs of EAN. |
CORD-19_Custom_license_subset
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T232 | 0-219 | Sentence | denotes | Our data indicate that in two different therapeutic regimens of active EAN and passive transfer EAN, ABR-215031 administered daily orally effectively ameliorated and inhibited the clinical and pathological signs of EAN. |